Contact Info
-
Phone:
Login to view phone number. -
Address:
Khasra No. 28/6, Dukhri Road, VPO Mohra, 13300 -
City:
Ambala City -
Country/Location:
India -
Website:
waylonehealthcare.in
Waylone Healthcare is a people-driven PCD Pharma Franchise Company in India that truly believes in making quality healthcare accessible to everyone. We’re passionate about delivering safe, effective, and affordable medicines that help improve lives every day.
Our range includes tablets, capsules, syrups, and injections — all manufactured in WHO-GMP certified facilities with strict quality standards. But what really sets us apart is our commitment to relationships. We don’t just offer products; we offer partnership, trust, and full support to help our franchise associates grow and succeed.
If you’re looking to start your own pharma business or expand your reach, Waylone Healthcare provides the perfect opportunity. We offer PCD Pharma Franchise partnerships with exclusive rights, marketing assistance, and reliable supply — so you can focus on growing your business confidently.
At Waylone Healthcare, we’re more than a pharma company — we’re a family of professionals dedicated to building a healthier India, one partnership at a time.
Our range includes tablets, capsules, syrups, and injections — all manufactured in WHO-GMP certified facilities with strict quality standards. But what really sets us apart is our commitment to relationships. We don’t just offer products; we offer partnership, trust, and full support to help our franchise associates grow and succeed.
If you’re looking to start your own pharma business or expand your reach, Waylone Healthcare provides the perfect opportunity. We offer PCD Pharma Franchise partnerships with exclusive rights, marketing assistance, and reliable supply — so you can focus on growing your business confidently.
At Waylone Healthcare, we’re more than a pharma company — we’re a family of professionals dedicated to building a healthier India, one partnership at a time.
Experience
-
Joined APSense.com
Nov 2025